HALL EUGENE A

SEC source: 0000749251-26-000267 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,188,228

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective May 1, 2024) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0000749251-26-000202 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,188,197

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective May 1, 2024) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0000749251-26-000120 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,188,159

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective May 1, 2024) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0000749251-26-000108 · form4.xml · derivative · entry 6

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,533

Underlying: Common Stock · 7,534 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 09, 2024. This represents the 2026 installment.

F3 · derivative.exercise_date: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 09, 2024. This represents the 2026 installment.

F3 · derivative.expiration_date: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 09, 2024. This represents the 2026 installment.

SEC source: 0000749251-26-000108 · form4.xml · derivative · entry 5

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,195 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: epresents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 09, 2023. This represents the 2026 installment.

F1 · derivative.exercise_date: epresents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 09, 2023. This represents the 2026 installment.

F1 · derivative.expiration_date: epresents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 09, 2023. This represents the 2026 installment.

SEC source: 0000749251-26-000108 · form4.xml · nonDerivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,188,120

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0000749251-26-000108 · form4.xml · nonDerivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,191,129

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 09, 2024. This represents the 2026 installment.

SEC source: 0000749251-26-000108 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,183,595

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0000749251-26-000108 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,187,268

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: epresents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 09, 2023. This represents the 2026 installment.

SEC source: 0000749251-26-000090 · form4.xml · derivative · entry 6

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,156

Underlying: Common Stock · 7,078 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 8, 2025. This represents the 2026 installment.

F3 · derivative.exercise_date: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 8, 2025. This represents the 2026 installment.

F3 · derivative.expiration_date: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 8, 2025. This represents the 2026 installment.

SEC source: 0000749251-26-000090 · form4.xml · nonDerivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,178,073

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0000749251-26-000090 · form4.xml · nonDerivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,180,610

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 8, 2025. This represents the 2026 installment.

SEC source: 0000749251-26-000090 · form4.xml · derivative · entry 5

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,386

Underlying: Common Stock · 4,463 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon the release of the performance-based RSUs awarded on February 6, 2025 and certified in February 2026. These performance-based RSUs convert into common stock on a one-for-one basis and vest in four substantially equal annual installments commencing on February 6, 2026. This represents the 2026 installment.

F1 · derivative.exercise_date: Represents shares acquired upon the release of the performance-based RSUs awarded on February 6, 2025 and certified in February 2026. These performance-based RSUs convert into common stock on a one-for-one basis and vest in four substantially equal annual installments commencing on February 6, 2026. This represents the 2026 installment.

F1 · derivative.expiration_date: Represents shares acquired upon the release of the performance-based RSUs awarded on February 6, 2025 and certified in February 2026. These performance-based RSUs convert into common stock on a one-for-one basis and vest in four substantially equal annual installments commencing on February 6, 2026. This represents the 2026 installment.

SEC source: 0000749251-26-000090 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,173,532

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0000749251-26-000090 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,174,770

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon the release of the performance-based RSUs awarded on February 6, 2025 and certified in February 2026. These performance-based RSUs convert into common stock on a one-for-one basis and vest in four substantially equal annual installments commencing on February 6, 2026. This represents the 2026 installment.

SEC source: 0000749251-26-000034 · form4.xml · derivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,053

Underlying: Common Stock · 96,053 shares

Expires 2033-02-05

F2 · derivative.exercise_date: These SARs become exercisable in four substantially equal annual installments, commencing on February 5, 2027.

F2 · derivative.expiration_date: These SARs become exercisable in four substantially equal annual installments, commencing on February 5, 2027.

SEC source: 0000749251-26-000034 · form4.xml · derivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,849

Underlying: Common Stock · 17,849 shares

Expires not disclosed

F1 · shares: These performance-based RSUs were awarded on February 6, 2025 and vest in four substantially equal annual installments, commencing on February 6, 2026. This represents the number of RSUs awarded after the performance metric was certified.

F1 · derivative.exercise_date: These performance-based RSUs were awarded on February 6, 2025 and vest in four substantially equal annual installments, commencing on February 6, 2026. This represents the number of RSUs awarded after the performance metric was certified.

F1 · derivative.expiration_date: These performance-based RSUs were awarded on February 6, 2025 and vest in four substantially equal annual installments, commencing on February 6, 2026. This represents the number of RSUs awarded after the performance metric was certified.

SEC source: 0000749251-25-000086 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,170,307

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective May 1, 2024) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-25-021130 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,170,281

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective May 1, 2024) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-25-016534 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,170,257

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective May 1, 2024) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-25-007930 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,170,243

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective May 1, 2024) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-25-004414 · form4.xml · derivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,938 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 10, 2022. This represents the 2025 installment.

F1 · derivative.exercise_date: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 10, 2022. This represents the 2025 installment.

F1 · derivative.expiration_date: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 10, 2022. This represents the 2025 installment.

SEC source: 0001127602-25-004414 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,170,231

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-25-004414 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,178,594

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 10, 2022. This represents the 2025 installment.

SEC source: 0001127602-25-003967 · form4.xml · derivative · entry 11

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,067

Underlying: Common Stock · 7,534 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 9, 2024. This represents the 2025 installment.

F4 · derivative.exercise_date: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 9, 2024. This represents the 2025 installment.

F4 · derivative.expiration_date: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 9, 2024. This represents the 2025 installment.

SEC source: 0001127602-25-003967 · form4.xml · derivative · entry 10

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,195

Underlying: Common Stock · 9,195 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 9, 2023. This represents the 2025 installment.

F3 · derivative.exercise_date: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 9, 2023. This represents the 2025 installment.

F3 · derivative.expiration_date: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 9, 2023. This represents the 2025 installment.

SEC source: 0001127602-25-003967 · form4.xml · nonDerivative · entry 6

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,157,656

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-25-003967 · form4.xml · nonDerivative · entry 5

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,160,665

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 9, 2024. This represents the 2025 installment.

SEC source: 0001127602-25-003967 · form4.xml · nonDerivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,153,131

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-25-003967 · form4.xml · nonDerivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,156,804

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents shares acquired upon the release of RSUs, which convert into common stock on a one-for-one basis. These RSUs vest in four substantially equal annual installments commencing on February 9, 2023. This represents the 2025 installment.

SEC source: 0001127602-25-003967 · form4.xml · derivative · entry 9

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,234

Underlying: Common Stock · 7,079 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon the vesting of the first installment of the RSUs in footnote 5 on February 8, 2025. These RSUs convert into common stock on a one-for-one basis.

F1 · derivative.exercise_date: Represents shares acquired upon the vesting of the first installment of the RSUs in footnote 5 on February 8, 2025. These RSUs convert into common stock on a one-for-one basis.

F1 · derivative.expiration_date: Represents shares acquired upon the vesting of the first installment of the RSUs in footnote 5 on February 8, 2025. These RSUs convert into common stock on a one-for-one basis.

SEC source: 0001127602-25-003967 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,147,609

F2 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-25-003967 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,150,326

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon the vesting of the first installment of the RSUs in footnote 5 on February 8, 2025. These RSUs convert into common stock on a one-for-one basis.

SEC source: 0001127602-25-003967 · form4.xml · derivative · entry 8

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,105

Underlying: Common Stock · 29,105 shares

Expires 2032-02-06

F6 · derivative.exercise_date: These SARs become exercisable in four substantially equal annual installments, commencing on February 6, 2026.

SEC source: 0001127602-25-003967 · form4.xml · derivative · entry 7

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,313

Underlying: Common Stock · 28,313 shares

Expires not disclosed

F5 · derivative.exercise_date: These performance-based RSUs were awarded on February 8, 2024 and vest in four substantially equal annual installments, commencing on February 8, 2025. This represents the number of RSUs awarded after the performance metric was certified.

F5 · derivative.expiration_date: These performance-based RSUs were awarded on February 8, 2024 and vest in four substantially equal annual installments, commencing on February 8, 2025. This represents the number of RSUs awarded after the performance metric was certified.

SEC source: 0001127602-24-028425 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,143,247

F1 · shares: Represents shares acquired under Gartner, Inc.'s 2011 Employee Stock Purchase Plan (as amended and restated effective May 1, 2024) in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).

SEC source: 0001127602-24-027910 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,143,235

SEC source: 0001127602-24-027726 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,143,385

SEC source: 0001127602-24-027088 · form4.xml · nonDerivative · entry 9

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,143,401

F8 · price: This transaction was executed in multiple trades at prices ranging from $549.72 to $550.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-24-027088 · form4.xml · nonDerivative · entry 8

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,144,610

F7 · price: This transaction was executed in multiple trades at prices ranging from $548.61 to $549.60. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-24-027088 · form4.xml · nonDerivative · entry 7

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,149,840

F6 · price: This transaction was executed in multiple trades at prices ranging from $547.45 to $548.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-24-027088 · form4.xml · nonDerivative · entry 6

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,151,155

F5 · price: This transaction was executed in multiple trades at prices ranging from $546.03 to $546.88. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-24-027088 · form4.xml · nonDerivative · entry 5

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,153,121

F4 · price: This transaction was executed in multiple trades at prices ranging from $545.00 to $545.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-24-027088 · form4.xml · nonDerivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,154,317

F3 · price: This transaction was executed in multiple trades at prices ranging from $544.00 to $544.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-24-027088 · form4.xml · nonDerivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,156,425

F2 · price: This transaction was executed in multiple trades at prices ranging from $543.00 to $543.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-24-027088 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,160,151

F1 · price: This transaction was executed in multiple trades at prices ranging from $542.00 to $542.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001127602-24-027088 · form4.xml · nonDerivative · entry 1

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,161,597

SEC source: 0001127602-24-026864 · form4.xml · derivative · entry 4

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,496

Underlying: Common Stock · 49,490 shares

Expires 2028-02-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These SARs are part of an award that became exercisable in four substantially equal annual installments, commencing on February 10, 2022, and are fully exercisable.

SEC source: 0001127602-24-026864 · form4.xml · nonDerivative · entry 3

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,161,697

F3 · shares: Represents shares withheld for the payment of applicable income and payroll withholding taxes.

SEC source: 0001127602-24-026864 · form4.xml · nonDerivative · entry 2

HALL EUGENE A · CIK 0001198849 · Director · Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,176,240

F2 · shares: Represents shares withheld that had an aggregate value, based on the market price on the date of exercise, substantially equal to the aggregate exercise price of the SARs.